€29.6 -0.2 -0.7%
Last Trade - 4:36pm
Market Cap | £1.02bn |
Enterprise Value | £1.35bn |
Revenue | £419.7m |
Position in Universe | 387th / 1046 |
Feb 27 (Reuters) - BIOTEST AG BIOG.DE : * DGAP-ADHOC: BIOTEST AG: BIOTEST REACHES FY 2017 EBIT GUIDANCE * FY REVENUE 378.1 MILLION EUR * MAIN REASON FOR DECLINE IN REVENUE WAS RECALL OF HUMAN ALBUMIN * FY EBIT GUIDANCE WAS REACHED WITH EUR 18 MILLION * 2017 REVENUE OF EUR 378.1 MILLION IN CONTINUING OPERATIONS, COMPARED TO EUR 408.0 MILLION IN PREVIOUS YEAR * ONE-OFF EXPENSES IN AMOUNT OF EUR 37.7 MILLION HAD A NEGATIVE IMPACT ON EBIT OF CONTINUING OPERATIONS * EBIT IN CONTINUING OPERATIONS AMOUNTED TO EUR -9.3 MILLION IN 2017 AFTER EUR 35.2 MILLION IN PREVIOUS YEAR Source text for Eikon: ID:nEQ5sdkTWa Further company coverage: BIOG.DE (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))